Skip to content

Author

Philipp Backhaus

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Per-patient Comparison of [68Ga]-FAPI-46 Versus [18F]FDG as PET Tracers in ER-positive Breast Cancer: Study Design of a Single-centre Prospective Study

Introduction. [18F]FDG can be considered as PET tracer to determine whole-body staging in patients with locally advanced (LABC), metastatic, and recurrent breast cancer. Yet, previous studies demonstrated a lower amount of metabolic accumulation on [18F]FDG PET in case of oestrogen receptor (ER)-positive breast cancer....

M. Lenaerts, L. Duijx, F. M. Mottaghy et al. · 0 citations
Open access Oct 2026

FAP-targeted [68Ga]BED003-PET compared with [18F]DOPA-PET in patients with recurrent medullary thyroid carcinoma

Molecular imaging of recurrent or advanced medullary thyroid carcinoma (MTC) remains clinically challenging. [ 18 F]DOPA-PET is an established reference standard, but its sensitivity is limited and dependent on tumour burden and biomarker levels. Fibroblast activation protein (FAP)-targeted PET has emerged as a...

D. Ventura, B. Noto, Philipp Backhaus et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.